Dietary flavonoids and insulin signaling in diabetes and obesity
MÁ Martín, S Ramos - Cells, 2021 - mdpi.com
Type 2 diabetes (T2D) and obesity are relevant worldwide chronic diseases. A common
complication in both pathologies is the dysregulation of the insulin-signaling pathway that is …
complication in both pathologies is the dysregulation of the insulin-signaling pathway that is …
Effect of Lampaya medicinalis Phil. (Verbenaceae) and Palmitic Acid on Insulin Signaling and Inflammatory Marker Expression in Human Adipocytes
G Yuri, M Cifuentes, P Cisternas, A Paredes… - Pharmaceuticals, 2024 - mdpi.com
Background: Aging and obesity are associated with insulin resistance (IR) and low-grade
inflammation. Molecularly, IR is characterized by a reduction in glucose uptake and insulin …
inflammation. Molecularly, IR is characterized by a reduction in glucose uptake and insulin …
Deleterious liver-adipose crosstalk in obesity: Hydroethanolic extract of Lampaya medicinalis Phil.(Verbenaceae) counteracts fatty acid-induced fibrotic marker …
G Yuri, S Sanhueza, A Paredes, G Morales… - Molecular and Cellular …, 2023 - Elsevier
Elevated circulating fatty acids in obesity may induce hepatic steatosis, leading to liver
inflammation, fibrosis and nonalcoholic fatty liver disease (NAFLD). On the other hand …
inflammation, fibrosis and nonalcoholic fatty liver disease (NAFLD). On the other hand …
[HTML][HTML] Antiplatelet activity of Lampaya medicinalis Phil. in human platelets
P Ormazabal, L Rodriguez, A Paredes, G Morales… - NFS Journal, 2022 - Elsevier
Herbal preparations can have beneficial effects to counteract cardiovascular diseases
(CVD). Inhibition of platelet aggregation have been shown to be effective in CVD treatment …
(CVD). Inhibition of platelet aggregation have been shown to be effective in CVD treatment …
[HTML][HTML] Efecto del extracto hidroalcohólico de la planta Lampaya medicinalis Phil. sobre marcadores inflamación inducidos por ácidos grasos en hepatocitos …
P Ormazabal, G Yuri, S Sanhueza… - Revista chilena de …, 2022 - SciELO Chile
Introducción: la enfermedad de hígado graso no alcohólico (EHGNA) se caracteriza por la
acumulación de gotas lipídicas (GL) y sobre expresión de la proteína de GL Perilipina 1 …
acumulación de gotas lipídicas (GL) y sobre expresión de la proteína de GL Perilipina 1 …